The Role of MYEOV Gene in Cancer: A Review and Future Directions
A recent study published in Frontiers in Oncology has shed light on the significant role of the MYEOV gene in various types of cancers, including multiple myeloma, breast cancer, lung cancer, pancreatic cancer, and esophageal cancer. The research highlights the gene's high expression levels in malignant tumors and its involvement in tumor cell signaling pathways and miRNA regulatory networks.
Key Takeaways:
- The MYEOV gene is overexpressed in multiple myeloma and various other malignant tumors, making it a potential oncogene.
- MYEOV plays a significant role in tumor cell signaling pathways and participates in miRNA regulatory networks as a competing endogenous RNA (ceRNA).
- Studies have shown that MYEOV may affect the expression of cancer-related genes through enhancer activity.
- The presence of the open reading frame of MYEOV in humans and other primates suggests its potential protein-coding capacity.
- Direct evidence of functional MYEOV protein is currently lacking, but research continues to uncover its role in cancer.
- The study suggests that MYEOV-targeted therapies hold promise for the treatment of various cancers.
Statistics:
- The MYEOV gene is detected in over 90% of multiple myeloma cases (The role of MYEOV gene: a review and future directions).
- The MYEOV gene is also highly expressed in breast cancer, lung cancer, pancreatic cancer, and esophageal cancer (The role of MYEOV gene: a review and future directions).
- Research has shown that MYEOV may affect the expression of over 100 cancer-related genes through enhancer activity (The role of MYEOV gene: a review and future directions).
Sources:
- "The role of MYEOV gene: a review and future directions" (Frontiers in Oncology, vol. 15, 2025)
- (Frontiers in Oncology - http://www.frontiersin.org/oncology)
- "General Hospital of Northern Theater Command Researchers Release New Data on Cancer (The role of MYEOV gene: a review and future directions)" (Hematology Week, June 16, 2025, p 1786)